Authors: VANDERGEEST R VANLAAR T KRUGER PP GUBBENSSTIBBE JM BODDE HE ROOS RAC DANHOF M

Citation: R. Vandergeest et al., PHARMACOKINETICS, ENANTIOMER INTERCONVERSION, AND METABOLISM OF R-APOMORPHINE IN PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE, Clinical neuropharmacology, 21(3), 1998, pp. 159-168

Authors: VANDERGEEST R KRUGER P GUBBENSSTIBBE JM VANLAAR T BODDE HE DANHOF M

Citation: R. Vandergeest et al., ASSAY OF R-APOMORPHINE, S-APOMORPHINE, APOCODEINE, ISOAPOCODEINE AND THEIR GLUCURONIDE AND SULFATE CONJUGATES IN PLASMA AND URINE OF PATIENTS WITH PARKINSONS-DISEASE, Journal of chromatography B. Biomedical sciences and applications, 702(1-2), 1997, pp. 131-141

Authors: VANDERGEEST R VANLAAR T GUBBENSSTIBBE JM BODDE HE DANHOF M

Citation: R. Vandergeest et al., IONTOPHORETIC DELIVERY OF APOMORPHINE II - AN IN-VIVO STUDY IN PATIENTS WITH PARKINSONS-DISEASE, Pharmaceutical research, 14(12), 1997, pp. 1804-1810

Authors: VANSCHAICK EA MATHOT RAA GUBBENSSTIBBE JM LANGEMEIJER MWE ROELEN HCPF IJZERMAN AP DANHOF M

Citation: Ea. Vanschaick et al., 8-ALKYLAMINO-SUBSTITUTED ANALOGS OF N-6-CYCLOPENTYLADENOSINE ARE PARTIAL AGONISTS FOR THE CARDIOVASCULAR ADENOSINE A(1) RECEPTORS IN-VIVO, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 800-808

Authors: MATHOT RAA GUBBENSSTIBBE JM SOUDIJN W JACOBSON KA IJZERMAN AP DANHOF M

Citation: Raa. Mathot et al., QUANTIFICATION OF THE IN-VIVO POTENCY OF THE ADENOSINE A(2) RECEPTOR ANTAGONIST 8-(3-CHLOROSTYRYL)CAFFEINE, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 245-253